Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Approved for marketing × OTHER × motexafin gadolinium × Clear all

Status

Completed 6 Withdrawn 1 Approved for marketing 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

gallium 68 PSMA-11 2 Magnetic Resonance Spectroscopy 2 motexafin gadolinium 1 glucarpidase 1 Positron-Emission Tomography 1 Oxaliplatin 1 Leucovorin 1 Laparoscopy 1 Gemtuzumab 1 Gadolinium 1 Fluorouracil 1 Carboxypeptidases 1 Amifampridine 1 3-Iodobenzylguanidine 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04809584 2024-12-19

18F-DCFPyL PET/MRI in Regional Nodal&Distant Metastases Detection in Intermediate &HR Prostate Cancer

Stanford University

Approved for marketing

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡